Optimization of ACE inhibitor therapy in heart failure

European Heart Journal

Volumn 23, Issue 17, 2002, Pages 1322-1323

  Doughty, R N ^a   Sharpe, N ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENOXIMONE; LISINOPRIL; MILRINONE;

DOSE RESPONSE; DRUG MECHANISM; EDITORIAL; EXERCISE; HEART ARRHYTHMIA; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HEART FAILURE, CONGESTIVE; HUMANS; TREATMENT OUTCOME;

EID: 0036760404     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2002.3225     Document Type: Editorial

References (8)

1. Cowley AJ, Skene AM on behalf of the Enoximone Investigators. Treatment of severe heart failure: Quantity or quality of life? A trial of enoximone. Br Heart J 1994; 72: 226-30.
2. Packer M, Carver JR, Rodeheffer RJ et al. for the PROMISE Study Research Group. Effect of oral milrinone on mortality in severe heart failure. N Engl J Med 1991; 325: 1468-75.
3. Cooke GA, Williams SG, Marshall P et al. A mechanistic investigation of ACE inhibitor dose effects on aerobic exercise capacity in heart failure patients. Eur Heart J 2002; 23: 1358-66.
4. Tang WHW, Vagelos RH, Yee Y-G et al. Neurohormonal and clinical responses to high-versus low-dose enalapril therapy in chronic heart failure. J Am Coll Cardiol 2002; 39: 70-8.
5. Packer M, Poole-Wilson Armstrong PW et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 1999; 100: 2312-8.
6. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-35.
7. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
8. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (n-BNP) concentrations. Lancet 2000; 355: 1126-30.